JULÄINE™️ of Sweden — Next-Generation Collagen Biostimulator.

The Need

As we age, the skin gradually loses firmness, density, and elasticity — a direct consequence of declining collagen production that begins as early as our mid-20s. The result: fine lines, loss of facial contour, dullness, and volume depletion in the mid-face. Today’s patients are increasingly moving away from the overfilled, “done” look, choosing instead a natural, gradual rejuvenation that rebuilds the skin from within rather than masking the signs of time. They expect results that are authentic, long-lasting, and — above all — safe, with no risk of nodules, inflammation, or granulomas occasionally associated with conventional poly-L-lactic acid (PLLA) products.

The Product

JULÄINE™️ is a premium Swedish injectable collagen biostimulator of a new generation, built on the patented LASYNPRO™️ technology — highly uniform, smooth poly-L-lactic acid (PLLA) microspheres. What sets JULÄINE™️ apart from earlier-generation PLLA products:

• Homogeneous, smooth microspheres — uniform size and regular surface architecture ensure optimal tissue integration and a predictable, controlled biostimulatory signal.
• Selective stimulation of Type I collagen — JULÄINE™️ activates fibroblasts to produce healthy structural collagen without triggering inflammatory pathways responsible for many of the adverse events reported with classical PLLA preparations (nodules, granulomas, fibrosis).
• Fast and effortless reconstitution, comfortable injection, minimal tissue trauma.
• Fully biocompatible and biodegradable, CE-marked, manufactured under ISO 13485:2016 medical device quality standards.
• Made in Sweden by Nordberg Medical, grounded in the latest research in regenerative skin science.

Patient Benefits

• Natural, gradual rejuvenation that develops over 2–3 months and lasts 12–18 months — up to 2 years in many patients, without ever looking artificial.
• Genuine improvement in skin quality: firmness, tone, density, elasticity, even pigmentation, and a signature glow effect visible after the first session.
• Significantly reduced risk of side effects typical of older-generation PLLA products — the LASYNPRO™️ technology minimises the likelihood of nodules, indurations, granulomas, and chronic inflammatory response.
• Minimal downtime — only transient redness or mild swelling that typically resolves within 1–3 days.
• Excellent safety profile — built on an endogenous substrate (lactic acid) with an extremely low allergenic potential.
• An investment in skin longevity — JULÄINE™️ does not fill; it rebuilds the structural scaffold of the skin, aligning with a downstream longevity philosophy and modern regenerative aesthetics.

Indications

Loss of facial firmness and contour, fine to moderate wrinkles, declining skin quality, acne scarring, post-weight-loss skin laxity, and preventive anti-ageing care for the well-informed patient.

Protocol

A series of 2–3 sessions every 4–6 weeks, with a maintenance treatment every 12–18 months. Performed exclusively by an experienced aesthetic physician at MedArte.